How to Buy Bicycle Therapeutics Stock
Bicycle Therapeutics PLC
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics.
Bicycle Therapeutics stock last closed at $24.69, up 2.02% from the previous day, and has increased 20.5% in one year. It has overperformed other stocks in the Biotechnology industry by 0.39 percentage points. Bicycle Therapeutics stock is currently +96.89% from its 52-week low of $12.54, and -14.6% from its 52-week high of $28.91.
At the moment, there are 42.78M BCYC shares outstanding. The market cap of BCYC is $1.06B. In the last 24 hours, 606,373 BCYC shares were traded.
How to Buy Bicycle Therapeutics Stock
Not sure how to invest in Bicycle Therapeutics stock? Here's how.
- Decide where to buy Bicycle Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Bicycle Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your method of payment and add your info.
- Analyze Bicycle Therapeutics stock: The Bicycle Therapeutics ticker symbol is BCYC. Is Bicycle Therapeutics stock a good investment? Should you buy shares of BCYC? How do BCYC's underlying business fundamentals look? Do top analysts think Bicycle Therapeutics is a good buy? Why has BCYC's stock price moved recently? (Hint: Our stock analysis website can help you figure out if BCYC is a good stock to buy).
- Place your BCYC trade: Decide if you will purchase BCYC shares at the current market price or use a limit order to purchase BCYC shares at a specific price.
- Watch your BCYC investment: Create a watchlist to important updates regarding your new investment in Bicycle Therapeutics shares.
Step 1: Decide where to buy Bicycle Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy BCYC stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you can buy BCYC today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new brokerage account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've finished signing up on a investment app, your next step is to transfer the money for your investment:
Watch the video below to see the process of depositing money into your new brokerage account.
Step 4: Analyze Bicycle Therapeutics stock
Once you have chosen the best place to buy Bicycle Therapeutics stock, it's critical to analyze their stock before you invest, so you truly wrap your head around the risk and opportunity.
Bicycle Therapeutics quick stats
Bicycle Therapeutics Due Diligence Checks
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on BCYC's stock page.
What is the fair value of BCYC stock?
You can use many financial metrics, analyses, models, and charts to gauge BCYC's intrinsic value.
Using relative valuations measures:
- BCYC could be undervalued based on its P/B ratio of 2.97x, relative to Biotechnology industry P/B ratio of 5.99x
You can do additional valuation analysis on BCYC's stock here.
A look at BCYC Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- BCYC has $457.00M in cash and short term investments. This is enough to cover its annual cash burn of $85.93M.
- BCYC has cash burn of 85928000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the BCYC balance sheet.
- There are more short-term assets than long-term liabilities on the BCYC balance sheet.
Failed Financial Due Diligence Checks:
- BCYC has a relatively high debt to equity ratio of 0.54.
- BCYC profit margin has gone up by 3.97 percentage points in the past year, but the company is still unprofitable.
Do Wall Street analysts think it's a good time to buy BCYC stock
Out of 6 Equities analysts who give ratings on BCYC, the consensus analyst rating on BCYC is a Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent BCYC Analyst Ratings
Jeffrey Hung, a top 12% analyst from Morgan Stanley maintains BCYC with a hold rating and lowers their BCYC price target from $42.00 to $40.00, on Nov 3, 2023.
You can dive deeper into what analysts are saying on the Bicycle Therapeutics stock forecast page.
BCYC Technical Indicators
How are BCYC Revenues/Earnings doing?
Last year, BCYC revenue was $41.61M. Over the past 5 year, BCYC's revenue has increased by 31.18% per year. This was faster than the Biotechnology industry average of 29.57%.
Find out more about BCYC's earnings and revenue performance here.
Are BCYC insiders buying or selling the stock?
Over the last 12 months, insiders at BCYC have sold more shares than they have bought.
Michael Charles Ferguson Hannay, CHIEF PROD SUPPLY CHAIN OFF of BCYC, was the latest BCYC insider to sell. They sold $5,779.93 worth of BCYC shares on Apr 11, 2024.
Learn more about who owns BCYC stock here.
Can I rely on BCYC as an income stream?
No, Bicycle Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about BCYC
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your BCYC trade
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, place a limit order.
Hit the Open button and your broker will execute your order.
If you want additional help buying stocks on eToro, click the helpful video below:
Step 6: Watch your BCYC investment
Now that you own some BCYC stock, you'll want to keep up with your new company.
Add BCYC to a watchlist to get alerted to the latest events about your BCYC stock.
BCYC Feed
How to Buy Stock in Bicycle Therapeutics
To summarize, here are the 6 steps to buy Bicycle Therapeutics stock:
- Decide where to buy Bicycle Therapeutics stock
- Open a brokerage account
- Deposit money your brokerage account
- Analyze Bicycle Therapeutics stock
- Place your BCYC trade
- Watch your BCYC investment
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest news on your investment in Bicycle Therapeutics, create a watchlist today.
Other Stock Buying Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.